CCL2 and breast carcinoma: CCL2 secreted by CAFs activates the NOTCH1 pathway that further induces CSC phenotype in the breast cancer cells, granting them self-renewal potential, indicating CCL2 as a potential target to block non-CSC-to-CSC switch (101).